News
-
New Hada Labo cleanser
Thursday | Nov 27 2025POPULAR Japanese skincare brand Hada Labo Tokyo has released a new addition to its White Range, the Make-Up Removing Micellar Water (RRP $22.95 for 400ml).
-
CWH fights MND
Thursday | Nov 27 2025CHEMIST Warehouse has raised $492,328.25 for motor neurone disease (MND) research through this year's FightMND campaign, reinforcing the retailer's commitment to the search for treatments, and ultimately a cure for the condition.
-
-
A year of growth and delivery
Wednesday | Nov 26 2025THE Pharmaceutical Society of Australia (PSA) has released its 2024/25 Annual Report, chronicling a year characterised by strong growth and delivery in terms of membership numbers, member support, training and education products and services, policy submissions, partnerships and general investment income.
-
TGA acts to restrict B6 with new S3 category
Wednesday | Nov 26 2025THE Therapeutic Goods Administration (TGA) has announced its decision to strengthen safety controls for products containing vitamin B6, with the aim of reducing the risk of nerve damage associated with the long-term consumption of high doses (PD 05 Jun).
-
Plant-based relief
Wednesday | Nov 26 2025THE Hey Sister! range of women's health products provide clinically proven relief for PMS, menopause and more.
-
Maximise your day
Wednesday | Nov 26 2025NEW Maxofen from Nova Pharmaceuticals combines paracetamol and ibuprofen for double-action relief from acute pain and fever.
-
Mini-mise pain
Wednesday | Nov 26 2025MEDICHOICE'S new Ibuprofen Mini liquid capsules provide rapid pain relief in an easy-to-swallow format.
-
eNRMC conformance stay of execution
Wednesday | Nov 26 2025THE transitional arrangement for the use of Electronic National Residential Medication Charts (eNRMC) has been extended again (PD 03 Oct), with systems that are non-conformant now no longer able to be used for prescriptions after 01 Apr 2026.
-
PBS revocation
Wednesday | Nov 26 2025THE Minister for Health and Ageing has advised that the Pharmaceutical Benefits Scheme (PBS) approval of Woodberry Community Chemist with Sokeo Seng as its sole director, has been revoked, effective 26 Sep 2025.
